| Collaborations |
|
LG Chemical Ltd
In May 2000, we established a five-year $30 million collaboration, with LG Chemical Ltd. to discover, develop and commercialize products for the treatment or prevention of human bacterial or fungal infections.
|
|
Incyte Corporation
In June 2000, we signed an alliance agreement with Incyte Genomics, Inc. under which we licensed the PathoSeqTM software, source code and trademark, and purchased the database and raw sequence data.
|
|
MediChem Life Sciences
In June 2001, we established a three-year joint research program with MediChem Life Sciences to discover and develop drug candidates for the treatment and prevention of microbial infections.
|